Nucleocapsid Protein

Nucleocapsid Protein

Nucleocapsid Protein Molekülinformation

Molecule Name
Nucleocapsid proteins
Molekülalias
Nucleocapsid Protein
Drug Development Progress
Anzahl der klinischen Arzneimittel2
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
Nucleocapsid Proteins

Nucleocapsid Protein Produktliste

Species
  • SARS-CoV-2(14)
  • HCoV-229E(1)
  • HCoV-NL63(1)
  • HCoV-OC43(1)
  • MERS(1)
  • SARS(1)
  • SFTS virus(1)
Tag
  • His Tag(18)
  • His Tag & Avi Tag(2)
Host
  • HEK293(13)
  • E. coli(7)
Conjugate
  • Unconjugated(18)
  • Biotin-labeled(2)
Grade
  • RUO(20)
Low Endotoxin
  • No(20)
You Have Viewed 1-10 Of 20 Results
  • 1
  • 2

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
ZelicapavirEDP-938; EP-023938Phase 2 ClinicalEnanta Pharmaceuticals Inc
Respiratory Syncytial Virus Infections
Details
PF-07923567RV-299; PF-07923567Phase 1 ClinicalReviral Ltd
Respiratory Syncytial Virus Infections
Details
Customer Reviews